Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HDAC Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01045538
What this trial is testing

Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer: Zolinza+XP

Who this might be right for
Gastric CancerHistone Deacetylase Inhibitor
Asan Medical Center 45
Testing effectiveness (Phase 2)Looking for participantsNCT05971758
What this trial is testing

Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease

Who this might be right for
Cushing Disease
University of California, Los Angeles 20
Testing effectiveness (Phase 2)Study completedNCT02588339
What this trial is testing

Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention

Who this might be right for
Graft Versus Host DiseaseGVHD
H. Lee Moffitt Cancer Center and Research Institute 42
Early research (Phase 1)Ended earlyNCT00127101
What this trial is testing

An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)

Who this might be right for
Lymphoma
Merck Sharp & Dohme LLC 23
Not applicableUnknownNCT01270399
What this trial is testing

Targeting ER-Golgi Homeostasis in an Advantageous Therapeutic Strategy in Lung Cancer

Who this might be right for
The Combined Effect of Hsp90 Inhibitor and HDAC/Proteasome Inhibitors on Lung Cancer Cell Fate and ER-Golgi Homeostasis Will be Examined.
Meir Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT00524667
What this trial is testing

HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
CancerCare Manitoba 6
Testing effectiveness (Phase 2)UnknownNCT01305499
What this trial is testing

A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Hetty Carraway 52
Testing effectiveness (Phase 2)Ended earlyNCT03233724
What this trial is testing

Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas

Who this might be right for
Carcinoma, Non-Small-Cell LungLung CancerNon-Small Cell Lung Cancer+2 more
National Cancer Institute (NCI) 9
Early research (Phase 1)Study completedNCT01902225
What this trial is testing

Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma

Who this might be right for
LymphomaT-Cell LymphomaCutaneous Lymphoma
Weiyun Ai 24
Early research (Phase 1)Ended earlyNCT00511576
What this trial is testing

Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors

Who this might be right for
Breast CancerLung CancerPulmonary Cancer+5 more
Mirati Therapeutics Inc. 54
Early research (Phase 1)Study completedNCT01149668
What this trial is testing

A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer

Who this might be right for
LymphomaNon-Hodgkin's LymphomaHodgkin Disease+3 more
Pharmacyclics LLC. 7
Testing effectiveness (Phase 2)Study completedNCT00357162
What this trial is testing

Belinostat in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
de Novo Myelodysplastic SyndromesPreviously Treated Myelodysplastic SyndromesSecondary Myelodysplastic Syndromes
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT00365599
What this trial is testing

Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 43
Early research (Phase 1)Study completedNCT01266057
What this trial is testing

Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 143
Early research (Phase 1)Study completedNCT01433731
What this trial is testing

Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL)

Who this might be right for
Lymphoma, T-Cell, Cutaneous
TetraLogic Pharmaceuticals 18
Large-scale testing (Phase 3)WithdrawnNCT03010865
What this trial is testing

Sodium Butyrate For Improving Cognitive Function In Schizophrenia

Who this might be right for
Schizophrenic DisorderCognitive Impairment
Shanghai Mental Health Center
Early research (Phase 1)Ended earlyNCT03710915
What this trial is testing

HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapsed and Refractory Multiple Myeloma
HitGen Inc. 3
Testing effectiveness (Phase 2)Study completedNCT00073385
What this trial is testing

Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Titan Pharmaceuticals 225
Testing effectiveness (Phase 2)Study completedNCT00404326
What this trial is testing

Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer

Who this might be right for
Cervical Cancer
National Institute of Cancerología 18
Testing effectiveness (Phase 2)Study completedNCT03820596
What this trial is testing

Sintilimab in Combination With Chidamide in Refractory and Relapsed ENKTCL

Who this might be right for
Safety and Efficacy
Huiqiang Huang 40
Next Page